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1. Introduction 
Stroke involves cerebral infarction and hemorrhaging and is associated with very high 
mortality. Previous reports have indicated that ischemic stimulation such as the 
reoxygenation that occurs after hypoxia produces a large quantity of reactive oxygen species 
(ROS) that strongly induces neuronal death in vivo and in vitro (Negishi et al., 2001). Indeed, 
this is considered to be the factor that most strongly induces cell death in cerebral ischemia. 
In recent years, apoptosis has been suggested to be the mechanism responsible for ischemic 
neuronal death in animal stroke models (Tagami et al., 1998). 
Stroke-prone spontaneously hypertensive rats (SHRSP) are widely used as a model of 
human stroke (Yamori et al., 1974). In this model, blood pressure is elevated as age 
increases, as is found in humans; and the rats eventually die of stroke. One feature of this 
model is that strokes develop spontaneously following severe hypertension (more than 150 
mmHg). Therefore, in SHRSP, because strokes develop after the onset of elevated blood 
pressure, elevated blood pressure is considered to be the most critical factor for stroke 
induction. However, interestingly, the neuronal cells of this model exhibit a great 
vulnerability compared with normal control WKY/Izm rats during the reoxygenation 
conditions following hypoxia (Tagami et al., 1998; Yamagata et al., 2010c). In addition to the 
influence of blood pressure in SHRSP/Izm rats, the neuronal vulnerability of this model 
strongly contributes to stroke development. SHRSP/Izm rats are susceptible to apoptosis 
under conditions of hypoxia and reoxygenation (H/R) (Tagami et al., 1998). The expression 
of antioxidant enzymes in SHRSP/Izm rats is attenuated in comparison with that in 
WKY/Izm rats. We highlight that this attenuation of antioxidant enzymes is related to the 
vulnerability of neuronal cells (Yamagata et al., 2000b). Furthermore, an altered 
susceptibility to apoptosis was detected in the astrocytes of SHRSP/Izm rats compared with 
those of WKY/Izm rats (Yamagata et al., 2010a). 
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Epidemiologic study indicated the possibility of preventing stroke using antioxidants 
such as dietary polyphenols (Vita, 2005). Polyphenols are substances produced by plants 
via photosynthesis, and their structures contain many hydroxyl groups (–OH). 
Polyphenols are found in vegetables, fruit, and processed products. They are also found 
abundantly in red wine, tea, soybeans, and coffee. The preventive effects of polyphenols 
include the inhibition of blood pressure elevation, cholesterol-lowering activity, 
hypoglycemic activity, antioxidant activity, and antimutagen activity (Sies et al., 2010). 
The effects of polyphenols differ between substances, but most are capable of 
"antioxidation". It is considered that the antioxidative effects of polyphenols are 
advantageous in their roles as defensive substances that protect plant components from 
oxidation. Polyphenols are found in trace amounts in our diet and have been 
demonstrated to prevent degenerative diseases such as cancer and cardiovascular disease 
(Manach et al., 2004). This review describes the vulnerability of neuronal cells and 
susceptibility of astrocytes in SHRSP in stroke conditions. Furthermore, we describe the 
prophylactic effects of apigenin, epigallocatechin-3-gallate (EGCG), and resveratrol on 
endothelial cells as well as their stroke preventive effects. 
2. Susceptibility of neuronal cells and astrocytes of SHRSP/Izm rats during 
cerebral ischemia 
The reoxygenation after cerebral ischemia rapidly generates a large quantity of ROS. The 
following chain of events leads to neuronal cell injury (Love, 1999). Free radicals are 
generated early in the period of the reperfusion and cause neuronal damage (Bolli, 1991). 
Cerebral ischemia–reperfusion induced neuronal cell death is usually apoptotic (Rothstein 
et al., 1994). Here, we describe alteration in neuronal cells and astrocytes related to apoptosis 
in SHRSP/Izm rats during H/R. 
2.1 Neuronal vulnerability of SHRSP during stroke and oxidative stress 
Neuronal death because of cerebral ischemic stress strongly induces apoptosis (Rothstein et 
al., 1994). Reports indicate that the production of hydroxyl radicals is strongly induced in 
SHRSP/Izm rats during H/R (Negishi et al., 2001). SHRSP/Izm and WKY/Izm rats produce 
hydroxyl radicals in their hippocampi when subjected to reoxygenation after 20 minutes of 
hypoxia. However, SHRSP/Izm rats display significantly increased hydroxyl production 
when compared with normal WKY/Izm control rats (Tagami et al., 1998). In SHRSP/Izm 
rats the production of hydroxyl radicals is strongly induced during H/R (Negishi et al., 
2001). The increased levels of hydroxyl radicals produced by SHRSP/Izm rats may induce 
neuronal injury. These findings suggest that capturing the hydroxyl radicals produced 
during H/R, in which the level of antioxidant substances is decreased, would be beneficial 
for preventing neuronal injury (Yamagata et al., 2010c). 
2.2 The neuronal cells of SHRSP/Izm rats strongly induce apoptosis during H/R 
Neuronal cells are easily damaged during H/R. We examined neuronal cells during hypoxia 
using SHRSP/Izm and WKY/Izm rats. After 24 hours of hypoxia, neuronal cell death was not 
observed in WKY/Izm or SHRSP/Izm rats. However, after 36 hours of hypoxia, neuronal cell 
death increased in SHRSP/Izm rats. This was not observed in WKY/Izm rats. The findings of 
a morphologic examination of SHRSP/Izm rats indicated that most neuronal cell death was 
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apoptotic. About 41% of the WKY/Izm neurons died 1.5 hours after reoxygenation (necrosis = 
12%, apoptosis = 29%). On the other hand, 78% of SHRSP/Izm neurons died (necrosis = 15%, 
apoptosis = 63%). Following three hours of reoxygenation, 99% of cells from both strains had 
died. In SHRSP/Izm rat neurons, fragmentation of DNA was strongly induced by 36 hours of 
hypoxia and reoxygenative stimulation for three hours (Tagami et al., 1998). The H/R induced 
apoptosis of neuronal cells in SHRSP/Izm rats (Yamagata et al., 2010c). The neuronal cells of 
SHRSP/Izm rats were strongly induced into apoptosis with 3 or 5 hours of reoxygenation 
following hypoxia. When DNA fragmentation was examined using a TUNEL method, few of 
the SHRSP/Izm rat neurons displayed DNA fragmentation when incubated under normal 
oxygen concentrations (data not shown). However, after 3 hours of reoxygenation following 36 
hours of hypoxia, marked DNA fragmentation was seen. At the same time, many lipid 
droplets were detected in the cells (Tagami et al., 1998). We classified the apoptotic levels in 
H/R conditions via a morphologic analysis of neuronal death (Tagami et al., 1998, 1999). We 
demonstrated the criteria for neuronal apoptosis in the SHRSP/Izm rats in Table 1 and Figure 
1. Neuronal axons and dendrites are lost in the early stages of apoptosis, and many lipid 
droplets are seen in the neuronal cell body (A, initial stage of apoptosis). Furthermore, cells 
shrink as apoptosis advances (B, second stage of apoptosis; C, third stage of apoptosis). The 
neuronal cell membrane is lost in the advanced stage of apoptosis, and the nucleus disappears 
(D). Figure 2 is considered to show the second stage of apoptosis (Tagami et al., 1998: 
Yamagata et al., 2010c). These processes eventually lead to cell death. From these results, it is 
suggested that the neuronal weakness of SHRSP/Izm rats is associated with stroke 
development (Fig. 4). 
 
 
Fig. 1. Our criteria to determine apoptosis and necrosis in neurons during H/R in 
SHRSP/Izm rats.  
A. initial stage, B, second stage, C. third stage and D necrosis (Tagami et al., 1998) 
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Fig. 2. Second stage of apoptosis in neurons during H/R in SHRSP/Izm rats. N: nucleus 
 
Stage Criteria of neuronal 
death 
Features of morphological 
1 Initial stage The cells lose their axons and dendrites,  
and numerous lipid droplets appear  
in the cell bodies, although cell  
organelles remain intact 
2 Second stage The cells become round, small, and electron-
dense, and their nuclei demonstrate 
prominent invagination 
3 Advanced stage The cells lose their cytoplasm and cell 
membrane, and their nuclei become  
small and dark before disappearing 
4 Final stage 
 
The cells become electron-lucent,  
organelles decrease in number, and  
nuclei contain abnormal clusters of 
chromatin (the cells lose their cytoplasm  
and cell membrane, and their nuclei  
become small and dark  
before disappearing) 
Cited references (Tagami et al., 1998, 1999). 
Table 1. The morphological criteria for neuronal apoptosis in the SHRSP/Izm rats. 
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2.3 Gene expression of Bcl2 and thioredoxin II in neuronal cells of SHRSP/Izm rats 
during H/R 
The apoptosis in neuronal cells of SHRSP/Izm is strongly induced by reperfusion after 
ischemia (Tagami et al., 1998). Simultaneously, oxidative stress can induce antioxidant 
enzymes in neuronal cells. Antioxidant enzymes can prevent the apoptosis caused by 
oxidation stress. Furthermore, the Bcl2 gene is an oncogene related to human lymphoma and 
is able to inhibit the apoptosis induced by neurodegeneration stimuli (Akhtar et al, 2004). 
We highlight that the Bcl2 gene expression in SHRSP/Izm rat neuronal cells is significantly 
attenuated after 30 minutes of reoxygenation following hypoxia in comparison with that in 
WKY/Izm rats (Yamagata et al., 2000b). The decrease in the expression of Bcl2 leads to 
release of the cytochrome C from mitochondria. Thereafter, caspase activity increases and 
can strongly induce apoptosis. In SHRSP/Izm rat neurons, gene expression of thioredoxin II 
(Txn2) and mitochondrial cytochrome c oxidase III (CO III) decreased in a fashion similar to 
Bcl2 30 minutes after reoxygenation following hypoxia (Yamagata et al., 2000b). Txn2 
provides protection against ROS via its SH group. In addition, these proteins have many 
functions that contribute to intracellular signal transduction. Namely, CO III is associated 
with energy metabolism in mitochondria. It transfers electrons from the reduced form of 
cytochrome C to molecular oxygen. Vitamin E and CO III are present in mitochondria where 
they protect the cell from injury by free radicals (Yang & Korsmeyer, 1996). Attenuation of 
Bcl2 and CO III gene expression in SHRSP/Izm rat neuronal cells may reduce energy 
metabolism and redox control during posthypoxic reoxygenation. The decrease of viability 
in SHRSP/Izm rat neurons, unlike that in WKY/Izm rat neurons, may be associated with 
their vulnerability. 
2.4 Characteristics of SHRSP/Izm rat astrocytes during stroke 
The functions of the astrocytes regulate outbreaks of cerebropathy (Chen & Swanson, 
2003). In brain lesions, reactive astrocyte numbers increase and promote the development 
of stroke (Pekny & Nilsson, 2005). This characteristic of the astrocytes of SHRSP/Izm rats 
may be related to brain disease (Chen & Swanson, 2003). We separated astrocytes from 
the brain of fetal SHRSP/Izm rats and cultured them. We compared the proliferation of 
astrocytes from WKY/Izm with SHRSP/Izm rats under various culture conditions 
(Yamagata et al., 1995). The astrocytes isolated from fetuses are not influenced by blood 
pressure. We examined the characteristics of astrocytes from SHRSP/Izm rats in 
environments that were not influenced by blood pressure. We found that the growth of 
astrocytes from SHRSP/Izm rats was increased in comparison with those from WKY/Izm 
rats (Yamagata et al., 1995). We suggest that the numbers of astrocytes of the SHRSP/Izm 
rats are increased and that this strongly leads to the gliosis following damage. In the rat 
brain transient cerebral ischemia model, epidermal growth factor (EGF) receptor is related 
to mechanism of astrocyte reactivity. The details are not known, but astrocyte numbers of 
SHRSP/Izm rats may increase by cell division through EGF stimulation during the 
appearance of cerebral blood vessel pathogenesis. This proliferation of astrocytes is 
enhanced by vascular smooth muscle cells in SHRSP/Izm rats (Yamori et al., 1981). In 
fibrinoid necrosis degeneration by hypertension, the barrier function of endothelial cells 
diminishes and blood plasma components leak out of the circulation (Johansson, 1999). In 
SHRSP/Izm rats, there is denaturation of smooth muscle cells of the media, necrosis with 
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a rise in blood pressure, and destruction of the blood–brain barrier (BBB) in perforating 
branch arteries (Tagami et al.,1987). We have indicated the possibility that attenuated 
endothelial barrier functions might be induced by comparing the astrocytic potency of 
SHRS/Izm rats (Yamagata et al., 1997b). 
Glutamate is released as a neurotransmitter by nerve terminals and activates astrocytes. 
Furthermore, glutamate uptake via a glutamate transporter in the cell membrane is 
mediated by astrocytes. Glutamate produces lactate in astrocytes and the lactate produced 
by astrocytes is supplied as an energy source to neuronal cells (Pellerin & Magistretti 1994). 
Concurrently, the lactate supplied by astrocytes is important for the recovery of the 
neuronal cells after ischemia (Schurr et al., 1997; Dringen et al., 1995). We demonstrated that 
there is decreased lactate produced in cultured astrocytes from SHRSP/Izm rats when 
compared with that from WKY/Izm rat astrocytes during hypoxia (Yamagata et al., 2000a). 
The decreased lactate production by SHRSP/Izm rat astrocytes may cause neuronal cell 
death through reduced energy supply. 
Furthermore, we examined characteristics of SHRSP/Izm rat astrocytes during stroke. In 
H/R, the expression levels of intercellular adhesion molecule-1 (ICAM1), monocyte 
chemotactic protein-1 (MCP1), and vascular cell adhesion molecule-1 (VCAM1) in 
astrocytes from SHRSP/Izm rats were increased in comparison with that in astrocytes 
from WKY/Izm rats (Yamagata et al., 2010a). In addition, production of glial cell line-
derived neurotrophic factor (GDNF) by adenosine, H2O2, glutamate, sphingosine-1-
phosphate (S1P) was decreased during H/R in astrocytes from SHRSP/Izm rats in 
comparison with that from astrocytes from WKY/Izm rats (Yamagata et al., 2002; 2003; 
2007a) (Fig. 3). Moreover, production of l-serine by nitric oxide (NO) stimulation 
decreased in SHRSP/Izm rats in comparison with that in WKY/Izm rats (Yamagata et al., 
2006). Not all of the differences seen in SHRSP/Izm rats compared with WKY/Izm rats 
may be related to the generation of neuronal dysfunction in SHRSP/Izm rats. However, 
decreased astrocytic lactate and GDNF production may worsen energy conditions and 
nutrition status of SHRSP/Izm rat neurons (Yamagata et al., 2008). We suggest that 
attenuation of astrocyte functions accelerates neuronal cell death during stroke and may 
participate in its appearance (Fig. 4). 
 
 
 
Fig. 3. Expression of GDNF in SHRSP/Izm rats by H/R stimulation.  
H/R: hypoxia and reoxygenation: S1P: sphingosine-1-phosphate,  
GDNF: glial cell line derived neurotrophic factor 
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Fig. 4. Alteration of astrocytes and neuronal apoptosis by H/R stimulation. 
3. Endothelial dysfunction and importance of stroke prevention through 
nutrition 
The risk of stroke increases with the presence of arteriosclerosis in cerebral blood vessel 
endothelial cells. Here, we describe preventive action for endothelial cell disorders by food 
components. The secretion of cytokines by initial lesions strongly activates endothelial cells, 
vascular smooth muscle cells, and blood cells. For example, endothelial cells are strongly 
influenced by the effects of inflammatory cytokines such as tumor necrosis factor alpha 
(TNF-) and interleukin beta (IL-1) (Kofler et al., 2005). As a consequence, monocytic 
adhesion to endothelial cells is induced, which promotes various arteriosclerotic processes. 
Among these, the oxidative stress produced during the early period of the disorder triggers 
arteriosclerosis. When the various arteriosclerotic reactions begin simultaneously, they are 
very difficult to inhibit. Therefore, it is best to inhibit ROS production in the early stages of 
the disorder in order to avoid arteriosclerosis (Kondo et al., 2009). Indeed, the effects of 
nutritional components with antioxidant activity on the redox regulation of ROS in stroke 
conditions have been reported previously. It is considered to be possible to inhibit blood 
vessel disorders in the early stages and that the inhibition of ROS production using 
polyphenols prevents the development of arteriosclerosis (Manach et al., 2004). Therefore, it 
is very likely that arteriosclerosis prevention via the consumption of appropriate foods such 
as antioxidant nutrients can be used to reduce the risk of stroke. 
3.1 Possible role of polyphenols against cerebral ischemia injury  
Cerebral ischemia induces the rapid production of a large quantity of ROS and induces cell 
injury through self-perpetuating reactions. Free radicals are produced within several 
minutes of reoxygenation after cerebral ischemia and induce brain cell injury (Bolli, 1991). 
Cerebral ischemia elevates the intracellular level of calcium ions and activates calcium-
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dependent proteases. Moreover, these reactions activate xanthine dehydrogenase (XDH) 
and produce xanthine oxidase (XOD) (Thompson-Gorman & Zweier, 1990). It is considered 
that the superoxide anion radicals produced via this pathway cause neuronal death. 
However, the consumption of polyphenol-rich foods, such as fruits and vegetables, is 
beneficial for preventing vascular disorders (Manach et al., 2004). Epidemiological studies 
have indicated that an inverse correlation exists between polyphenolic consumption and the 
risk of having to undergo a cardiovascular procedure (Arts & Hollman, 2005). Polyphenols 
induce the production of vasodilatory factors such as NO (Auger et al., 2010) and 
prostacyclin (PGI2) (Mizugaki et al., 2000) and inhibit the synthesis of endothelin-1, which 
induces vasoconstriction in endothelial cells (Reiter et al., 2010). On the other hand, the 
polyphenols present in the skin of grapes and in wine inhibit the proliferation and migration 
of smooth muscle cells (Lee et al., 2009). Polyphenols may eliminate the active oxygen 
produced by reoxygenation after cerebral ischemia via their antioxidative effects. 
3.2 Vasorelaxant effects of polyphenols on endothelial cells 
Epidemiological analysis has suggested that polyphenols have protective effects against heart 
disease. The polyphenols that protect against heart disease are found in foods including cocoa, 
wine, grape pips, berries, tea, tomatoes, soybeans, and pomegranates (Chong et al., 2010). The 
mechanisms by which polyphenols reduce the risk of heart disease are associated with the 
prevention of endothelial cell disorders. Endothelial cell disorders strongly induce 
arteriosclerosis, which subsequently progresses to heart disease and stroke. Therefore, the 
prevention of endothelial cell disorders by polyphenols is effective in preventing heart disease 
and stroke. Table 2 shows the effects of the typical polyphenols apigenin, EGCG, and 
resveratrol on endothelial cells. Jin et al. (2009) demonstrated that apigenin (0.5 – 72.0 M) 
enhanced concentration-dependent relaxation in aortas. Apigenin action is mediated by 
weakening the oxidative stress and by NO reduction. On the other hand, it has been shown 
that stimulation of expression of endothelial NOS (eNOS) by apigenin occurs through 
phosphatidylinositol 3-kinase/Akt (PI3K/Akt) for Ca2+ dependence (Chen et al., 2010). 
Moreover, the blockade of adhesion of monocytes and cyclooxygenase (COX)-2 expression in 
endothelial cells by apigenin has been reported (Lee et al., 2007). We have shown that apigenin 
strongly inhibits high glucose- and TNF--induced VCAM1 expression and the adhesion of 
U937 in human endothelial cells (Yamagata et al., 2010b). These effects of apigenin are caused 
by the inhibition of Iionkinase (IKK)  and IKK/IKKi. From these findings, we suggested that 
the mechanism by which apigenin inhibits the expression of adhesion molecules and the 
adhesion of monocytic U937 to endothelial cells involves nuclear factor kappa beta (NF-). 
From the structure and inhibitory activity profiles of dietary flavonoids, it was recognized that 
the double bond found in the C-ring of flavonoids and the third hydroxyl group (A-ring) are 
required for the inhibition of VCAM1 gene expression (Yamagata et al., 2010b). Apigenin may 
inhibit monocytic adhesion caused by superoxide anions as well as block reductions in NO 
activity. From these reports, it is considered that apigenin reduces the levels of ROS, promotes 
NO activity, and inhibits cell adhesion. Moreover, apigenin strongly inhibited the TNF--
stimulated expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) 
(Yamagata et al., 2011) and the double bond of the C ring of apigenin is essential for this action 
(Fig. 5). As shown in Figure. 5, the inhibition of LOX-1 expression by apigenin requires a 
flavone frame, a double bond in the C-ring, and the absence of a third hydroxyl group in the B- 
and C-rings, which are not found in naringenin (not active) (Yamagata et al., 2011). 
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Polyphenol(s) Effects on pathological condition(s) Ref  
(authors and issue)  
Apigenin Endothelium-dependent vasorelaxant and 
antiproliferative effect 
Zhang  
et al (2000)  
Inhibiton of VEGF Osada  
et al., (2004)  
Inhibiton of laser-induced choroidal 
neovascularization 
Zou and Chiou 
(2006)  
Inhibition of COX-2 expression and adhesion of 
monocytes 
Lee et al., (2007)  
Inhibition of superoxide anion-mediated impairment Ma  
et al., (2008)  
Inhibition of platelet adhesion and thrombus 
formation 
Navarro-Nunez  
et al., (2008)  
Protection against the oxidative stress by the NO Jin et al., (2009)  
Induction of calcium dependent activation of the NO Chen  
et al., (2010)  
Inhibition of high glucose and TNFα-induced 
adhesion molecule expression 
Yamagata  
et al., (2010b)  
Inhibition of TNFα-induced LOX-1 expression Yamagata  
et al., (2011)  
EGCG Increase of the prostacyclin production Mizugaki  
et al., (2000)  
Inhibition of the vascular-endothelial growth factor-
induced intracellular signaling and mitogenesis 
Neuhaus  
et al., (2004)  
Inhibits the angiotensin II-induced adhesion molecule 
expression 
Chae et al., (2007)   
Inhibiton of MCP-1 expression Hong et al., (2007)  
Improves endothelial function and insulin sensitivity, 
reduces blood pressure, and protects against 
myocardial I/R injury in SHR 
Potenza  
et al., (2007)  
Inhibiton of TNFα-induced MCP-1 production Ahn et al., (2008)  
Protection against linoleic-acid-induced endothelial 
cell activation 
Zheng et al., (2009)  
Decrease of caveolin-1 expression Li et al., (2009)  
Decrease of endothelin-1 expression and secretion Reiter et al., (2010)  
Induction of the NO Auger et al., (2010)  
Protection of against oxidized LDL-induced 
endothelial dysfunction 
Lee et al., (2010)  
Protects against oxidized LDL-induced endothelial 
dysfunction by inhibiting LOX-1-mediated signaling 
Ou et al., (2010)  
Decreases thrombin/paclitaxel-induced endothelial 
tissue factor expression 
Wang et al., (2010)  
inhibiton of angiotensin II-induced endothelial barrier 
dysfunction 
Yang et al., (2010)  
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Resveratrol Inhibition of angiogenesis, tumor growth,  
and wound healing 
Brakenhielm  
et al., (2001)  
Prevention of superoxide-dependent  
inflammatory responses induced by I/R,  
PAF, or oxidants. 
Shigematsu  
et al., (2003)  
Inhibition of VEGF-induced angiogenesis Lin  
et al., (2003)  
Protection against peroxynitrite-mediated  
endothelial cell death 
Brito et al., (2006)  
Attenuation of TNF alpha-induced activation; 
inhibition of NF-kappaB  
Csiszar et al., (2006)  
Inhibition of MCP-1 synthesis and secretion Cullen et al., (2007)  
Attenuates oxLDL-stimulated NADPH  
oxidase activity and protects endothelial  
cells from oxidative functional damages. 
Chow et al (2007)  
Prevention of concentric hypertrophy and  
diastolic impairment 
Juric et al., (2007)  
Induction of NO production by increasing  
estrogen receptor alpha 
Klinge et al., (2008)  
Induction of NADPH oxidases 1 and 4 mediate 
cellular senescence 
Schilder  
et al., (2009)  
Reduces oxidative stress by modulating  
the gene expression of SOD1,  
GPx1 and Nox4 
Spanier et al (2009)  
Decrease of mitochondrial oxidative stress Ungvari  
et al., (2009)  
Prevention of hyperglycemia-induced  
endothelial dysfunction 
Xu et al., (2009)  
Decrease of oxidized LDL-evoked  
LOX-1 signaling 
Chang  
et al., (2011)  
Protecton of H 2O2-induced oxidative stress Kao  
et al., (2010)  
Protecton of oxidized LDL-induced  
breakage of the blood-brain  
barrier 
Lin et al., (2010)  
COX; cyclooxygenase, GPx1; glutathione peroxidase 1, I/R; ischemia/reperfusion, LDL; low density 
lipoprotein, LOX-1; lectin-like oxidized low-density lipoprotein receptor-1, MCP-1; monocyte 
chemotactic protein-1, NO; nitric oxide, Nox4; NADPH oxidase subunit, PAF; platelet-activating factor, 
SOD1; superoxide dismutase 1, SHR, spontaneously hypertensive rats, TNF; tumor necrosis factor, 
VEGF; vascular endothelial growth factor,  
Table 2. Studies on the protective effects of apigenin, EGCG and resveratrol in endothelial 
cells  
EGCG is a catechin that is found in green tea. The catechins found in tea include epicatechin 
(EC), epigallocatechin (EGC), epicatechin gallate (ECG), and epigallocatechin gallate 
www.intechopen.com
Ischemic Neurodegeneration in Stroke-Prone  
Spontaneously Hypertensive Rats and Its Prevention with Antioxidants Such as Polyphenols 
 
13 
(EGCG), and the content order of these compounds is as follows: EGCG>EGC>ECG>EC. 
Catechins are also responsible for the bitter taste of green tea. Catechins account for around 
13%–30% of the dry weight of tea leaves (Wolfram, 2007). EGCG suppresses the expression 
of adhesion molecules such as MCP1 (Ahn et al., 2008; Chae et al., 2007; Hong et al., 2007) 
and expression of endothelin-1 (Reiter et al., 2010). Like apigenin, EGCG inhibits the 
expression of monocyte adhesion molecules in endothelial cells stimulated with TNF- 
(Ahn et al., 2008; Zheng et al., 2010) and it has been reported that EGCG inhibits the TNF--
induced expression of activator protein-1 in endothelial cells and increased the expression of 
HO-1. These findings suggest that EGCG inhibits the expression of activator protein-1 and 
increases the expression of HO-1, both of which aid endothelial protection. Furthermore, a 
least one study demonstrated that EGCG downregulated the endothelial cell activation 
induced by linoleic acid via caveolin-1 (Zheng et al., 2009). Six hours of linoleate exposure 
induced the expression of caveolin-1 and COX-2 in caveolae. However, pretreatment with 
EGCG inhibited the expression of caveolin-1 and COX-2 induced by linoleic acid. Exposure 
to linoleic acid also increased the levels of several kinases (p38 MAPK, extracellular signal 
regulated kinase 1/2 8ERK1/2), and amino kinase terminal (Akt). According to these 
findings, EGCG activates several enzymes in endothelial cell caveolae and may have many 
preventive effects for vascular disorders. 
 
 
 
 
 
Fig. 5. Structures and LOX-1 inhibitory activities of apigenins. 
○: active (indicates that the compound dose-dependently inhibited TNFα-induced LOX-1 
gene expressions).  
Many studies have demonstrated that ischemic heart disease is decreased by wine intake, 
and in particular, it has been shown that the antioxidative effects of the polyphenols 
found in red wine are important for cardioprotection. It was shown that this 
cardioprotective effect is caused by the actions of resveratrol. It has been confirmed that 
resveratrol displays various pharmacologic actions such as antioxidant activity in humans 
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(Brito et al., 2006; Chow et al., 2007; Spanier et al., 2009; Ungvari et al., 2009). Resveratrol 
is considered to decrease circulating low-density lipoprotein (LDL) cholesterol levels and 
thereby reduce the risk of cardiovascular disease (CVD) (Ramprasath & Jones, 2010). 
Resveratrol inhibits atherosclerosis and improves the function of endothelial cells in 
animal models. There have been many studies of resveratrol actions, which have shown 
that it has various effects on endothelial cells, as shown in Table 2. The effects of 
resveratrol and red wine on endothelial cells were investigated using experimental 
hypercholesterolemic rabbits (Zou et al., 2003). It was found that hypercholesterolemic 
rabbits displayed significant improvements in the functions of their endothelial cells after 
the administration of resveratrol (3 mg/kg/day), red wine (4 ml/kg/day), or 
nonalcoholic red wine (4 ml/kg/day) for 12 weeks. Moreover, they demonstrated 
decreased levels of plasma endothelin-1 and NO, which are increased by 
hypercholesterolemia. On the other hand, it was also shown that resveratrol protects 
against injury to the BBB caused by oxidized LDL (oxLDL) (Lin et al., 2010). It is 
considered that the mechanism behind these effects of resveratrol involves amelioration of 
the effects of oxLDL on the expression of occludin and ZO-1, which aids the stability of 
tight junctions. Resveratrol regulates the expression of tight junction proteins as a means 
of protecting against the disruption of the BBB induced by oxLDL. In a rat postischemic 
reoxygenation model, resveratrol decreased ROS generation (Shigematsu et al., 2003), and 
the effect of resveratrol on cerebral infarction was also examined in a rat middle cerebral 
artery occlusion (MCA) model (Sinha et al., 2002). In addition, after MCA and 2 hours of 
reperfusion, the rats were evaluated for motor disorders, malondialdehyde (MDA), 
reduced glutathione, and infarct volume. After MCA, increases in the frequency of 
functional motility disorders and the levels of MDA and reduced glutathione were 
observed. On the other hand, the administration of resveratrol prevented these increases 
and significantly decreased the infarct volume. These findings indicate that resveratrol 
inhibits the organ injuries produced by ischemia–reperfusion. The other polyphenols 
found in wine are not known to have this effect. Correspondingly, resveratrol prevents 
myocardial infarction by reducing peroxide levels. It is suggested that this effect can be 
attributed to the antioxidative effects of resveratrol (Dudley et al., 2008). 
4. Preventive effects of antioxidant drugs and polyphenols for SHRSP rat 
neurons during stroke 
We indicated that high dose vitamin E induced neutral gamma glutamylcystenyl synthase 
(-GCS), GSH levels, and strongly prevented neuronal death (Yamagata et al., 2009). 
Furthermore, we have shown that ebselen, a seleno–organic antioxidant (Yamagata et al., 
2008), amlodipine, and carvedilol (Yamagata et al., 2004) prevented neuronal cell death in 
SHRSP/Izm rats. Another study demonstrated that the expression of VCAM1 by TNF- 
in astrocytes isolated from SHRSP/Izm rats was increased compared with that in those 
from WKY/Izm rats. However, apigenin strongly attenuated TNF--induced VCAM1 
mRNA and protein expression and suppressed the adhesion of U937 cells and 
SHRSP/Izm astrocytes (Yamagata et al., 2010a). It is suggested that apigenin regulates 
adhesion molecule expression in reactive astrocytes during ischemia and prevents 
neuronal death. 
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5. Conclusion 
Endothelial cell dysfunction causes arteriosclerosis and promotes neuronal demise after stroke. 
Enhanced neuronal sensitivity to oxidative stress contributes to the neuronal death observed 
in SHRSP/Izm rats. Also, enhanced oxidative stress after hypoxia-reoxygenation is important 
in ischemic stroke. Polyphenols reduce oxidation stress and have a protective effect on 
endothelial and neuronal cells. Antioxidant nutrients such as polyphenols may prevent or 
reduce endothelial dysfunction and neuronal cell injury during cerebral ischemia. 
6. Abbreviations 
BBB; blood–brain barrier, CO III; cytochrome c oxidase III, COX; cyclooxygenase, CVD; 
cardiovascular disease, EC; epicatechin, ECG; epicatechin gallate, EGC; epigallocatechin, 
EGCG; epigallocatechin-3-gallate, EGF; epidermal growth factor, eNOS; endothelial NOS, -
GCS; gamma glutamylcystenyl synthase, GDNF; glial cell line-derived neurotrophic factor, 
GSH: glutathione, HO-1; hemoxigenase-1, H/R; hypoxia and reoxygenation, ICAM1; 
intercellular adhesion molecule-1, IL-1; interleukin beta, IKK; IIKKkinase, LDL; low-
density lipoprotein, LOX-1; lectin-like oxidized low-density lipoprotein receptor-1, MCP1; 
monocyte chemotactic protein-1, NO; nitric oxide, NF-; nuclear factor kappa beta, oxLDL; 
oxidized LDL, PGI2; prostacyclin, PI3K/Akt; phosphatidylinositol 3-kinase/Akt, ROS; 
reactive oxygen species, SHRSP/Izm; spontaneously hypertensive rats/Izm, S1P; 
sphingosine-1-phosphate, TNF-; tumor necrosis factor alpha, TRX; thioredoxin, VCAM1; 
vascular cell adhesion molecule-1, WKY/Izm; Wistar Kyoto rat/Izm, XDH; xanthine 
dehydrogenase, XOD; xanthine oxidase.  
Keywords; Endothelial cells, Ischemic stroke, Polyphenol, SHRSP. 
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